During the past decade, VMR Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "VMR Institute" are "Vitrectomy" (1 trials) and "Vitreomacular Adhesion" (1 trials). Many other conditions were trialed in "VMR Institute" in a lesser frequency.

Most popular intervention types in "VMR Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "125 µg Ocriplasmin" (1 trials), "Ocriplasmin 125µg" (1 trials), "Ocriplasmin 25µg" (1 trials) and "Ocriplasmin 75µg" (1 trials). Other intervention names were less common.

The vast majority of trials in "VMR Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "VMR Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in VMR Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in VMR Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".